Polyrizon ltd PLRZ.US 總覽分析
PLRZ 投資分析
看多重點：
- 價值≥4
- 股利≥2
分析結論
公司發布財報數據季度不足，尚無法提供評分
PLRZ 近期報酬表現
298.58%
Polyrizon ltd
3.56%
同產業平均
1.47%
S&P500
與 PLRZ 同產業的標的表現
- RGLS Regulus therapeutics incorporated價值 3 分趨勢 5 分波段 2 分籌碼 1 分股利 1 分查看更多
PLRZ 公司資訊
Polyrizon Ltd is an Israel-based biotechnology company. The Company is primarily engaged and specializing in the development of medical device hydrogels delivered in the form of nasal sprays, which form a thin hydrogel-based shield containment barrier in the nasal cavity that can provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. Its naturally occurring building blocks, is delivered in the form of nasal sprays, and potentially functions as a biological mask with a thin shield containment barrier in the nasal cavity. The Company is focused not only on the development of intranasal products, but also on commercialization. The Company cooperates with medical specialists and researchers..